Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
12.01
+0.31 (2.65%)
At close: Jul 27, 2026, 4:00 PM EDT
12.01
0.00 (0.00%)
After-hours: Jul 27, 2026, 4:04 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $1.05 billion as of July 27, 2026. Its market cap has increased by 225.52% in one year.
Market Cap
1.05B
Enterprise Value
547.65M
1-Year Change
225.52%
Ranking
Category
Stock Price
$12.01
ChartMarket Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $1.05B, a decrease of -41.54%. That is a compound annual growth rate of -9.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 1.05B | -46.65% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.10B |
| MeiraGTx Holdings | 1.09B |
| Cullinan Therapeutics | 1.05B |
| Vor Biopharma | 1.04B |
| Alto Neuroscience | 1.04B |
| Inventiva | 1.03B |
| EyePoint | 1.02B |
| Lexicon Pharmaceuticals | 1.02B |